{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:39:19Z","timestamp":1790959159943,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R00HL121087"],"award-info":[{"award-number":["R00HL121087"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL130512"],"award-info":[{"award-number":["R01HL130512"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL125583"],"award-info":[{"award-number":["R01HL125583"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 HL089856"],"award-info":[{"award-number":["U01 HL089856"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 HL089897"],"award-info":[{"award-number":["U01 HL089897"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","award":["ECLIPSE"],"award-info":[{"award-number":["ECLIPSE"]}],"id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008184","name":"COPD Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008184","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Introduction<\/jats:title>\n<jats:p>Cachexia contributes to increased mortality and reduced quality of life in Chronic Obstructive Pulmonary Disease (COPD) and may be associated with underlying gene expression changes. Our goal was to identify differential gene expression signatures associated with COPD cachexia in current and former smokers.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>We analyzed whole-blood gene expression data from participants with COPD in a discovery cohort (COPDGene, <jats:italic>N<\/jats:italic>\u2009=\u2009400) and assessed replication (ECLIPSE, <jats:italic>N<\/jats:italic>\u2009=\u2009114). To approximate the consensus definition using available criteria, cachexia was defined as weight-loss &gt;\u20095% in the past 12\u2009months or low body mass index (BMI) (&lt;\u200920\u2009kg\/m<jats:sup>2<\/jats:sup>) and 1\/3 criteria: decreased muscle strength (six-minute walk distance &lt;\u2009350\u2009m), anemia (hemoglobin &lt;\u200912\u2009g\/dl), and low fat-free mass index (FFMI) (&lt;\u200915\u2009kg\/m<jats:sup>2<\/jats:sup> among women and\u2009&lt;\u200917\u2009kg\/m<jats:sup>2<\/jats:sup> among men) in COPDGene. In ECLIPSE<jats:bold><jats:italic>,<\/jats:italic><\/jats:bold> cachexia was defined as weight-loss &gt;\u20095% in the past 12\u2009months or low BMI and 3\/5 criteria: decreased muscle strength, anorexia, abnormal biochemistry (anemia or high c-reactive protein (&gt;\u20095\u2009mg\/l)), fatigue, and low FFMI. Differential gene expression was assessed between cachectic and non-cachectic subjects, adjusting for age, sex, white blood cell counts, and technical covariates. Gene set enrichment analysis was performed using MSigDB.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The prevalence of COPD cachexia was 13.7% in COPDGene and 7.9% in ECLIPSE<jats:italic>.<\/jats:italic> Fourteen genes were differentially downregulated in cachectic versus non-cachectic COPD patients in COPDGene (FDR\u2009&lt;\u20090.05) and ECLIPSE (FDR\u2009&lt;\u20090.05).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Discussion<\/jats:title>\n<jats:p>Several replicated genes regulating heme metabolism were downregulated among participants with COPD cachexia. Impaired heme biosynthesis may contribute to cachexia development through free-iron buildup and oxidative tissue damage.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12931-020-01336-w","type":"journal-article","created":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T02:03:33Z","timestamp":1588298613000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Heme metabolism genes Downregulated in COPD Cachexia"],"prefix":"10.1186","volume":"21","author":[{"given":"Ava C.","family":"Wilson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti L.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sool","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret M.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itika","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarrett D.","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiel F. M.","family":"Wouters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Casaburi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen I.","family":"Rennard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Lomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvar","family":"Agusti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Tal-Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Dransfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Michael","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surya P.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Washko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor J.","family":"Thannickal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemant K.","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig P.","family":"Hersh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Castaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin K.","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merry-Lynn N.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,1]]},"reference":[{"issue":"1","key":"1336_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.chest.2018.02.014","volume":"154","author":"A Marengoni","year":"2018","unstructured":"Marengoni A, Vetrano DL, Manes-Gravina E, Bernabei R, Onder G, Palmer K. The relationship between COPD and frailty: a systematic review and meta-analysis of observational studies. Chest. 2018;154(1):21\u201340.","journal-title":"Chest."},{"issue":"9","key":"1336_CR2","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1152\/japplphysiol.00790.2012","volume":"114","author":"AH Remels","year":"2013","unstructured":"Remels AH, Gosker HR, Langen RC, Schols AM. The mechanisms of cachexia underlying muscle dysfunction in COPD. J Appl Physiol (1985). 2013;114(9):1253\u201362.","journal-title":"J Appl Physiol (1985)"},{"key":"1336_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12931-014-0139-5","volume":"16","author":"RA Rabinovich","year":"2015","unstructured":"Rabinovich RA, Drost E, Manning JR, Dunbar DR, D\u00edaz-Ramos M, Lakhdar R, et al. Genome-wide mRNA expression profiling in vastus lateralis of COPD patients with low and normal fat free mass index and healthy controls. Respir Res. 2015;16:1.","journal-title":"Respir Res"},{"issue":"3","key":"1336_CR4","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/jcsm.12078","volume":"7","author":"A Lewis","year":"2016","unstructured":"Lewis A, Lee JY, Donaldson AV, Natanek SA, Vaidyanathan S, Man WD, et al. Increased expression of H19\/miR-675 is associated with a low fat-free mass index in patients with COPD. J Cachexia Sarcopenia Muscle. 2016;7(3):330\u201344.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"1336_CR5","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1164\/rccm.200605-704OC","volume":"176","author":"M Doucet","year":"2007","unstructured":"Doucet M, Russell AP, L\u00e9ger B, Debigar\u00e9 R, Joanisse DR, Caron MA, et al. Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;176(3):261\u20139.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"1336_CR6","first-page":"58","volume":"10","author":"MM Parker","year":"2017","unstructured":"Parker MM, Chase RP, Lamb A, Reyes A, Saferali A, Yun JH, et al. RNA sequencing identifies novel non-coding RNA and exon-specific effects associated with cigarette smoking. BMC Med Genet. 2017;10(1):58.","journal-title":"BMC Med Genet"},{"issue":"1","key":"1336_CR7","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12931-019-1073-3","volume":"20","author":"MN McDonald","year":"2019","unstructured":"McDonald MN, Wouters EFM, Rutten E, Casaburi R, Rennard SI, Lomas DA, et al. It's more than low BMI: prevalence of cachexia and associated mortality in COPD. Respir Res. 2019;20(1):100.","journal-title":"Respir Res"},{"issue":"1","key":"1336_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3109\/15412550903499522","volume":"7","author":"EA Regan","year":"2010","unstructured":"Regan EA, Hokanson JE, Murphy JR, Make B, Lynch DA, Beaty TH, et al. Genetic epidemiology of COPD (COPDGene) study design. COPD. 2010;7(1):32\u201343.","journal-title":"COPD."},{"issue":"4","key":"1336_CR9","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1183\/09031936.00111707","volume":"31","author":"J Vestbo","year":"2008","unstructured":"Vestbo J, Anderson W, Coxson HO, Crim C, Dawber F, Edwards L, et al. Evaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE). Eur Respir J. 2008;31(4):869\u201373.","journal-title":"Eur Respir J"},{"issue":"4","key":"1336_CR10","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1164\/rccm.201204-0596PP","volume":"187","author":"J Vestbo","year":"2013","unstructured":"Vestbo J, Hurd SS, Agust\u00ed AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347\u201365.","journal-title":"Am J Respir Crit Care Med"},{"key":"1336_CR11","doi-asserted-by":"publisher","unstructured":"McDonald MN, Diaz AA, Rutten E, Lutz SM, Harmouche R, San Jose Estepar R, et al. Chest computed tomography-derived low fat-free mass index and mortality in COPD. Eur Respir J. 2017;50(6)1701134. https:\/\/doi.org\/10.1183\/13993003.01134-2017.","DOI":"10.1183\/13993003.01134-2017"},{"issue":"6","key":"1336_CR12","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","volume":"27","author":"WJ Evans","year":"2008","unstructured":"Evans WJ, Morley JE, Argil\u00e9s J, Bales C, Baracos V, Guttridge D, et al. Cachexia: a new definition. Clin Nutr. 2008;27(6):793\u20139.","journal-title":"Clin Nutr"},{"issue":"3","key":"1336_CR13","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1183\/09031936.00104507","volume":"31","author":"CG Cote","year":"2008","unstructured":"Cote CG, Casanova C, Mar\u00edn JM, Lopez MV, Pinto-Plata V, de Oca MM, et al. Validation and comparison of reference equations for the 6-min walk distance test. Eur Respir J. 2008;31(3):571\u20138.","journal-title":"Eur Respir J"},{"issue":"4","key":"1336_CR14","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s00520-004-0734-y","volume":"13","author":"S Van Belle","year":"2005","unstructured":"Van Belle S, Paridaens R, Evers G, Kerger J, Bron D, Foubert J, et al. Comparison of proposed diagnostic criteria with FACT-F and VAS for cancer-related fatigue: proposal for use as a screening tool. Support Care Cancer. 2005;13(4):246\u201354.","journal-title":"Support Care Cancer"},{"key":"1336_CR15","doi-asserted-by":"publisher","unstructured":"Leek JT. svaseq: removing batch effects and other unwanted noise from sequencing data. Nucleic Acids Res. 2014;42(21). https:\/\/doi.org\/10.1093\/nar\/gku864.","DOI":"10.1093\/nar\/gku864"},{"issue":"2\u20133","key":"1336_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ygeno.2016.01.004","volume":"107","author":"Y Chang","year":"2016","unstructured":"Chang Y, Glass K, Liu YY, Silverman EK, Crapo JD, Tal-Singer R, et al. COPD subtypes identified by network-based clustering of blood gene expression. Genomics. 2016;107(2\u20133):51\u20138.","journal-title":"Genomics."},{"issue":"9","key":"1336_CR17","doi-asserted-by":"publisher","first-page":"e107381","DOI":"10.1371\/journal.pone.0107381","volume":"9","author":"D Singh","year":"2014","unstructured":"Singh D, Fox SM, Tal-Singer R, Bates S, Riley JH, Celli B. Altered gene expression in blood and sputum in COPD frequent exacerbators in the ECLIPSE cohort. PLoS One. 2014;9(9):e107381.","journal-title":"PLoS One"},{"issue":"3","key":"1336_CR18","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","volume":"20","author":"L Gautier","year":"2004","unstructured":"Gautier L, Cope L, Bolstad BM, Irizarry RA. Affy--analysis of Affymetrix GeneChip data at the probe level. Bioinformatics. 2004;20(3):307\u201315.","journal-title":"Bioinformatics."},{"issue":"2","key":"1336_CR19","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1186\/gb-2014-15-2-r29","volume":"15","author":"CW Law","year":"2014","unstructured":"Law CW, Chen Y, Shi W, Smyth GK. voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 2014;15(2):R29.","journal-title":"Genome Biol"},{"issue":"9","key":"1336_CR20","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1093\/bioinformatics\/bti270","volume":"21","author":"GK Smyth","year":"2005","unstructured":"Smyth GK, Michaud J, Scott HS. Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics. 2005;21(9):2067\u201375.","journal-title":"Bioinformatics."},{"key":"1336_CR21","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/1471-2105-12-322","volume":"12","author":"JA Miller","year":"2011","unstructured":"Miller JA, Cai C, Langfelder P, Geschwind DH, Kurian SM, Salomon DR, et al. Strategies for aggregating gene expression data: the collapseRows R function. BMC Bioinformatics. 2011;12:322.","journal-title":"BMC Bioinformatics"},{"key":"1336_CR22","volume-title":"GeneOverlap: Test and visualize gene overlaps. R package version 1.22.0 ed","author":"L Shen","year":"2019","unstructured":"Shen L. GeneOverlap: Test and visualize gene overlaps. R package version 1.22.0 ed; 2019."},{"key":"1336_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/978-1-4939-0512-6_9","volume":"1150","author":"A Liberzon","year":"2014","unstructured":"Liberzon A. A description of the molecular signatures database (MSigDB) web site. Methods Mol Biol. 2014;1150:153\u201360.","journal-title":"Methods Mol Biol"},{"issue":"9","key":"1336_CR24","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1164\/rccm.201702-0311PP","volume":"196","author":"SM Cloonan","year":"2017","unstructured":"Cloonan SM, Mumby S, Adcock IM, Choi AMK, Chung KF, Quinlan GJ. The \"Iron\"-y of Iron overload and Iron deficiency in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2017;196(9):1103\u201312..","journal-title":"Am J Respir Crit Care Med"},{"key":"1336_CR25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/nm.4021","volume":"22","author":"SM Cloonan","year":"2016","unstructured":"Cloonan SM, Glass K, Laucho-Contreras ME, Bhashyam AR, Cervo M, Pab\u00f3n MA, et al. Mitochondrial iron chelation ameliorates cigarette smoke-induced bronchitis and emphysema in mice. Nat Med. 2016;22:163\u201374.","journal-title":"Nat Med"},{"key":"1336_CR26","doi-asserted-by":"publisher","unstructured":"Sato K, et al. Effect of Iron Deficiency on a Murine Model of Smoke-Induced Emphysema. Am J Respir Cell Mol Biol. 2019. https:\/\/doi.org\/10.1165\/rcmb.2018-0239OC.","DOI":"10.1165\/rcmb.2018-0239OC"},{"issue":"1","key":"1336_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/gm122","volume":"2","author":"NA Stephens","year":"2010","unstructured":"Stephens NA, Gallagher IJ, Rooyackers O, Skipworth RJ, Tan BH, Marstrand T, et al. Using transcriptomics to identify and validate novel biomarkers of human skeletal muscle cancer cachexia. Genome Med. 2010;2(1):1.","journal-title":"Genome Med"},{"key":"1336_CR28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41420-019-0151-0","volume":"5","author":"FV Mello","year":"2019","unstructured":"Mello FV, Land MGP, Costa ES, Teod\u00f3sio C, Sanchez ML, B\u00e1rcena P, et al. Maturation-associated gene expression profiles during normal human bone marrow erythropoiesis. Cell Death Discov. 2019;5:69.","journal-title":"Cell Death Discov"},{"issue":"2","key":"1336_CR29","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.cmet.2009.07.007","volume":"10","author":"TA Rouault","year":"2009","unstructured":"Rouault TA, Tong WH. Tangled up in red: intertwining of the heme and iron-sulfur cluster biogenesis pathways. Cell Metab. 2009;10(2):80\u20131.","journal-title":"Cell Metab"},{"issue":"1","key":"1336_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.blre.2006.03.005","volume":"21","author":"J Delaunay","year":"2007","unstructured":"Delaunay J. The molecular basis of hereditary red cell membrane disorders. Blood Rev. 2007;21(1):1\u201320.","journal-title":"Blood Rev"},{"issue":"3","key":"1336_CR31","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.bbrc.2016.08.090","volume":"478","author":"J Wu","year":"2016","unstructured":"Wu J, Wang J, Zeng X, Chen Y, Xia J, Wang S, et al. Protein phosphatase 2A regulatory subunit B56\u03b2 modulates erythroid differentiation. Biochem Biophys Res Commun. 2016;478(3):1179\u201384.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"1336_CR32","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.devcel.2014.07.021","volume":"30","author":"CS Thom","year":"2014","unstructured":"Thom CS, Traxler EA, Khandros E, Nickas JM, Zhou OY, Lazarus JE, et al. Trim58 degrades dynein and regulates terminal erythropoiesis. Dev Cell. 2014;30(6):688\u2013700.","journal-title":"Dev Cell"},{"key":"1336_CR33","doi-asserted-by":"crossref","first-page":"358283","DOI":"10.1155\/2010\/358283","volume":"2010","author":"T Tanno","year":"2010","unstructured":"Tanno T, Miller JL. Iron loading and overloading due to ineffective erythropoiesis. Adv Hematol. 2010;2010:358283.","journal-title":"Adv Hematol"},{"key":"1336_CR34","doi-asserted-by":"crossref","unstructured":"Soler Artigas M, Wain LV, Repapi E, Obeidat M, Sayers I, Burton PR, et al. Effect of five genetic variants associated with lung function on the risk of chronic obstructive lung disease, and their joint effects on lung function. Am J Respir Crit Care Med. 2011;184(7):786\u201395.","DOI":"10.1164\/rccm.201102-0192OC"},{"key":"1336_CR35","doi-asserted-by":"crossref","unstructured":"Zhang BL, Xu RL, Qin YW, Zheng X, Wu H, You XH, et al. Potential candidate genes for alveolar hypoxia identified by transcriptome network analysis. Medicina (Kaunas). 2012;48(11):572\u201380.","DOI":"10.3390\/medicina48110084"},{"key":"1336_CR36","first-page":"199","volume":"6","author":"BD Kent","year":"2011","unstructured":"Kent BD, Mitchell PD, McNicholas WT. Hypoxemia in patients with COPD: cause, effects, and disease progression. Int J Chron Obstruct Pulmon Dis. 2011;6:199\u2013208.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"7","key":"1336_CR37","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.3324\/haematol.2014.105809","volume":"99","author":"B Zhao","year":"2014","unstructured":"Zhao B, Keerthivasan G, Mei Y, Yang J, McElherne J, Wong P, et al. Targeted shRNA screening identified critical roles of pleckstrin-2 in erythropoiesis. Haematologica. 2014;99(7):1157\u201367.","journal-title":"Haematologica."},{"issue":"15","key":"1336_CR38","doi-asserted-by":"publisher","first-page":"8780","DOI":"10.1073\/pnas.151179498","volume":"98","author":"G Nicolas","year":"2001","unstructured":"Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A, et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci U S A. 2001;98(15):8780\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"1336_CR39","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.4161\/cc.28760","volume":"13","author":"MM Bellet","year":"2014","unstructured":"Bellet MM, Piobbico D, Bartoli D, Castelli M, Pieroni S, Brunacci C, et al. NEDD4 controls the expression of GUCD1, a protein upregulated in proliferating liver cells. Cell Cycle. 2014;13(12):1902\u201311.","journal-title":"Cell Cycle"},{"issue":"4","key":"1336_CR40","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/SPC.0b013e328331e91c","volume":"3","author":"AM Schols","year":"2009","unstructured":"Schols AM, Gosker HR. The pathophysiology of cachexia in chronic obstructive pulmonary disease. Curr Opin Support Palliat Care. 2009;3(4):282\u20137.","journal-title":"Curr Opin Support Palliat Care"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-020-01336-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-020-01336-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-020-01336-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T12:50:42Z","timestamp":1620046242000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-020-01336-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1336"],"URL":"https:\/\/doi.org\/10.1186\/s12931-020-01336-w","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,1]]},"assertion":[{"value":"15 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Institutional Review Board approval for all analyses was obtained from the University of Alabama at Birmingham and have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All subjects included in this analysis provided written informed consent prior to their inclusion in the respective studies mentioned below.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"ACW, PLK, SL, MMP, IA, HKT, VJT, GW, MW, AA, SR, and RC report no conflicts of interest. JM reports grants from NIH NHLBI, during the conduct of the study. EW reports board membership for Nycomed and Boehringer, grants from AstraZeneca and GlaxoSmithKline, and payment for lectures including service on speakers\u2019 bureaus from GlaxoSmithKline, Novartis, and Chiesi. DL has received grant support, honoraria and consultancy fees from GSK. SPB is supported by NIH grant K23HL133438. He has served on advisory boards for Sunovion and GlaxoSmithKline. CH reports grants from National Institutes of Health, during the conduct of the study; personal fees from AstraZeneca, personal fees from Concert Pharmaceuticals, personal fees from 23andMe, grants from Novartis, grants from Boehringer-Ingelheim, outside the submitted work. EKS received grants and travel support from GlaxoSmithKline within the past three years. MLM reports grants from NIH, other from Parker B. Francis Foundation, during the conduct of the study; personal fees from Pfizer, outside the submitted work. RTS reports personal fees from GlaxoSmithKline, during the conduct of the study. MTD reports grants from NIH, American Lung Association, Department of Defense, and the Department of Veterans Affairs; personal fees from AstraZeneca, Boehringer Ingelheim, PneumRx\/BTG, Mereo, Quark Pharmaceuticals and GSK, and contracted clinical trial support from Boehringer Ingelheim, Novartis, AstraZeneca, Yungjin, PneumRx\/BTG, Pulmonx, Boston Scientific, Gala, Nuvaira, and GSK. PJC has received research support and consulting fees from GSK and Novartis. JMW reports grants from NIH\/NHLBI, during the conduct of the study; grants from NIH\/NCATS, grants from Bayer, grants and other from GSK, other from Boehringer Ingelheim, grants and other from Mereo BioPharma, other from PRA, outside the submitted work; .","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"100"}}